0001209191-18-052076.txt : 20180924
0001209191-18-052076.hdr.sgml : 20180924
20180924181252
ACCESSION NUMBER: 0001209191-18-052076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180924
FILED AS OF DATE: 20180924
DATE AS OF CHANGE: 20180924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patterson Matthew R
CENTRAL INDEX KEY: 0001401018
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37833
FILM NUMBER: 181084349
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Audentes Therapeutics, Inc.
CENTRAL INDEX KEY: 0001628738
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461606174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
BUSINESS PHONE: 415-638-6556
MAIL ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-24
0
0001628738
Audentes Therapeutics, Inc.
BOLD
0001401018
Patterson Matthew R
C/O AUDENTES THERAPEUTICS, INC.
600 CALIFORNIA STREET, 17TH FLOOR
SAN FRANCISCO
CA
94108
1
1
0
0
Chief Executive Officer
Common Stock
2018-09-24
4
M
0
15000
0.78
A
15000
D
Common Stock
171814
I
By Matthew R. Patterson Revocable Trust
Stock Option (right to buy)
0.78
2018-09-24
4
M
0
15000
0.00
D
2023-09-25
Common Stock
15000
92702
D
The reporting person is the trustee of the Matthew R. Patterson Revocable Trust.
The option vested as to 25% of the total shares on January 1, 2014, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on January 1, 2017, subject to the reporting person's provision of service to the issuer on each vesting date and to accelerated vesting in the event of the occurrence of certain events.
/s/ Thomas Soloway as attorney-in-fact for Matthew Patterson
2018-09-24